| Monoclonal antibody | |
|---|---|
| Source | Mouse |
| Target | MUC1 |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Intraperitoneal |
| Identifiers | |
| ATC code | None |
| Chemical data | |
| Formula | ? |
| (what is this?) (verify) |
|
Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour.[1] As of 2009[update], it is undergoing Phase III clinical trials.[2]
It has been granted orphan drug status in Europe.[3]